SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Journal of Renin-Angiotensin-Aldosterone System
This Article
Right arrow Abstract Freely available
Right arrow Free Full Text (Free PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Letizia, C.
Right arrow Articles by D'Erasmo, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Letizia, C.
Right arrow Articles by D'Erasmo, E.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

High plasma adrenomedullin concentrations in patients with high-renin essential hypertension

Claudio Letizia

Department of Clinical Science, Chair of Internal Medicine, University of Rome "La Sapienza", Rome, Italy, claudio.letizia@ uniroma1.it

Stefano Subioli

Department of Clinical Science, Chair of Internal Medicine, University of Rome "La Sapienza", Rome, Italy

Sabrine Cerci

Department of Clinical Science, Chair of Internal Medicine, University of Rome "La Sapienza", Rome, Italy

Chiara Caliumi

Department of Clinical Science, Chair of Internal Medicine, University of Rome "La Sapienza", Rome, Italy

Cristiana Verrelli

Department of Clinical Science, Chair of Internal Medicine, University of Rome "La Sapienza", Rome, Italy

Enrica Delfini

Department of Clinical Science, Chair of Internal Medicine, University of Rome "La Sapienza", Rome, Italy

Massimiliano Celi

Department of Clinical Science, Chair of Internal Medicine, University of Rome "La Sapienza", Rome, Italy

Luigi Scuro

Department of Clinical Science, Chair of Internal Medicine, University of Rome "La Sapienza", Rome, Italy

Emilio D'Erasmo

Department of Clinical Science, Chair of Internal Medicine, University of Rome "La Sapienza", Rome, Italy

Adrenomedullin (AM) is a novel peptide, first isolated from human phaeochromocytoma, which elicits a long-lasting vasorelaxant activity. Recently, it has been reported that endothelial cells produce AM and that immunoreactive AM plasma levels may be elevated in human arterial hypertension, although the exact pathophysiological role of AM remains to be established.

The aim of our study was to determine the relationship between the components of the renin-angiotensin-aldosterone system (RAAS) and plasma AM levels in patients with low-, medium- or high-renin essential hypertension.

The study groups included 10 patients with low-renin essential hypertension (average age 42 15 years), nine patients with medium-renin essential hypertension (46 13 years), 11 patients with high-renin essential hypertension (42 14 years) and 12 healthy subjects (43 11 years).

Our results demonstrated that the mean AM values of all patients with essential hypertension were 10.85 3.14 pg/ml; there was a statistical correlation (r=0.705; p<0.001) between plasma renin activity (PRA) and AM levels in hypertensives.

In patients with high-renin essential hypertension, plasma AM levels (14.2 2.2 pg/ml) were significantly higher (p<0.001) than those of healthy subjects (8.7 2.1 pg/ml), patients with medium-renin essential hypertension (8.5 1.4 pg/ml), and patients with low-renin essential hypertension (9.1 1.5 pg/ml). There was no statistical difference in AM concentrations between medium- and low-renin hypertensive patients. In conclusion, we have found that, in hypertensive patients, plasma AM levels were increased only in high-renin individuals, suggesting a role of AM in this particular form of human essential hypertension.

Key Words: adrenomedullin • essential hypertension • renin-angiotensin-aldosterone system

References

  • Kitamura K., Kangawa K., Kawamoto M. et al. Adrenomedullin, a novel hypotensive peptide isolated from human pheochromocytoma. Biochem Biophys Res Commun 1993;192:553-60.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Ichiki Y.,Kitamura K., Kangawa K., Kawamoto M., Matsuo H., Eto T. Distribution and characterization of immunoreactive adrenomedullin in human tissue and plasma. FEBS Lett 1994; 338:6-10.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Sato K., Hirata J., Irai T., Iwashina M., Marmo F. Characterization of immmunoreactive adrenomedullin in human plasma and urine. Life Sci 1995;57:189-94.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Di Iorio R., Marinoni E., Scavo D., Letizia C., Cosmi EV Adrenomedullin in pregnancy (letter). Lancet 1997;349:328. 5. Ishiyama Y., Kitamura K., Ichiki Y. et al. Haemodynamic effects of a novel hypotensive peptide, human adrenomedullin in rats. EurJPharmacol 1993;241:271-3.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Nakamura M.,Yoshida H., Makita S.,Arakawa N., Niinuma H., Hiramori K. Potent and long-lasting vasodilatory effects of adrenomedullin in humans. Comparison between normal subjects and patients with chronic heart failure. Circulation 1997; 95:1214-21.[Abstract/Free Full Text]
  • Ebara T., Miura K., Okumura M., Matsuura T., Kim S.,Yikimura T. Effect of adrenomedullin on renal hemodynamics and functions in dogs. Eur J Pharmacol 1994; 263:69-73.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Nagaya N., Nishikimi T., Horio T., Yoshihara F., Kanazawa A., Matsuo H. Cardiovascular and renal effects of adrenomedullin in rats with heart failure.AmJPhysiol 1999;276:R213-18.[Web of Science][Medline] [Order article via Infotrieve]
  • Fukuhara M., Tsuchihashi T., Abe I., Fusishima M. Cardiovascular and neurohormonal effects of intravenous adrenomedullin in conscious rabbits. Am J Physiol 1995;269: R1289-93.[Web of Science][Medline] [Order article via Infotrieve]
  • Khono M., Hanemira T., Kano H. et al. Plasma adrenomedullin concentrations in essential hypertension. Hypertension 1996;27:102-07.[Abstract/Free Full Text]
  • Kato J., Kitamura K., Kuwasako K. et al. Plasma adrenomedullin in patients with primary aldosteronism. Am J Hypertens 1995;8:997-1000.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Letizia C., De Toma G., Cerci S. et al.Adrenomedullin levels are high in primary aldosteronism due to adenoma and decline after surgical cure. Blood Press 1998;7:19-23.[CrossRef][Medline] [Order article via Infotrieve]
  • Letizia C., De Toma G., Caliumi C. et al. Plasma adrenomedullin concentrations in patients with adrenal pheochromocytoma. Horm Metab Res 2001;33:290-4.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Yamaguchi T., Baba K., Doi Y., Yano K. Effect of adrenomedullin on aldosterone secretion by dispersed rat adrenal zona glomerulosa cells. Life Sci 1995;56:379-87.[Web of Science][Medline] [Order article via Infotrieve]
  • Yamaguchi T., Baba K., Doi Y., Yano K., Kitamura K., Eto T. Inhibition of aldosterone production by adrenomedullin, a hypotensive peptide in the rat. Hypertension 1996;28:308-14.[Abstract/Free Full Text]
  • Nicholls MG, Lainchbury JG, Lewis LK et al. Bioactivity of adrenomedullin and proadrenomedullin N-terminal 20 peptide in man. Peptides 2001;22:1745-52.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Laragh JH Role of the renin-angiotensin-aldosterone axis in human hypertensive disorders. In: Kaplan N, Brenner B, Laragh JH (eds.). The kidney in hypertension. New York: Raven Press, 1987;35-51.
  • Eto TA review of the biological properties and clinical implications of adrenomedullin and pro-adrenomedullin N-terminal 20 peptide (PAMP), hypotensive and vasodilating peptide. Peptides 2001;22:1693-711.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • NishikimiT, Saito Y., Kitamura K., IshimitsuT, Eto T., Kangawa K. Increased plasma adrenomedullin in patients with heart failure. J Am Coll Cardiol 1995;26:1424-31.[Abstract]
  • KitaT., Kitamura K., Kuwasako K., Kawamoto M., Eto T. Short-term modulation of the renin-angiotensin system does not alter plasma adrenomedullin concentration in humans. J Hypertens 1998;16:2057-62.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Jensen BL, Kramer BK, KurtzA. Adrenomedullin stimulates renin release and renin mRNA in mouse juxtaglomerular granular cells. Hypertension 1997;29:1148-55.[Abstract/Free Full Text]
  • Andreis PG, Mazzocchi G., Rebuffat P., Nussdorfer GG Effect of adrenomedullin and proadrenomedullin-N-terminal 20 peptide on rat zona glomerulosa cells. Life Sci 1997;60:1693-7.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Nagaya N., Satoh T., Nishikimi T. et al. Hemodynamic, renal, and hormonal effects of adrenomedullin infusion in patients with congestive heart failure. Circulation 2000;101:498-503.[Abstract/Free Full Text]
  • Troughton RW, Lewis LK, Yandle TG, Richards M., Nicholls MG Hemodynamic, hormone, and urinary effects of adrenomedullin infusion in essential hypertension. Hypertension 2000;36:588-93.[Abstract/Free Full Text]
  • Charles CJ, Nicholls MG, Rademaker MT, Richards AM Comparative actions of adrenomedullin and nitroprusside: interaction with ANG II and norepinephrine. Am J Physiol Regul Integr Comp Physiol 2001;281:R1887-94.[Abstract/Free Full Text]
  • Petrie MC, McDonald JE, Hillie RC, Morton JJ, McMurray JJV.Effects of adrenomedullin on angiotensin II-stimulated atrial natriuretic peptide and arginine vasopressin secretion in healthy humans. BrJPharmacol 2001;52:165-8.[CrossRef]

Journal of Renin-Angiotensin-Aldosterone System, Vol. 3, No. 2, 126-129 (2002)
DOI: 10.3317/jraas.2002.014


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?



This Article
Right arrow Abstract Freely available
Right arrow Free Full Text (Free PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Letizia, C.
Right arrow Articles by D'Erasmo, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Letizia, C.
Right arrow Articles by D'Erasmo, E.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Advertisement